PMC:7534795 / 59121-59430 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T237","span":{"begin":84,"end":89},"obj":"Body_part"}],"attributes":[{"id":"A237","pred":"fma_id","subj":"T237","obj":"http://purl.org/sig/ont/fma/fma67264"}],"text":"N-3 PUFAs and many of the their endogenously generated metabolites act as bioactive lipid molecules with a wide array of properties against numerous disorders including CVD (Lordan, Redfern, Tsoupras, \u0026 Zabetakis, 2020; Lordan, Tsoupras, \u0026 Zabetakis, 2017; Moro, Nagahashi, Ramanathan, Takabe, \u0026 Wakai, 2016)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T349","span":{"begin":105,"end":106},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"N-3 PUFAs and many of the their endogenously generated metabolites act as bioactive lipid molecules with a wide array of properties against numerous disorders including CVD (Lordan, Redfern, Tsoupras, \u0026 Zabetakis, 2020; Lordan, Tsoupras, \u0026 Zabetakis, 2017; Moro, Nagahashi, Ramanathan, Takabe, \u0026 Wakai, 2016)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T192","span":{"begin":4,"end":9},"obj":"Chemical"},{"id":"T79903","span":{"begin":55,"end":66},"obj":"Chemical"},{"id":"T194","span":{"begin":84,"end":89},"obj":"Chemical"},{"id":"T2816","span":{"begin":90,"end":99},"obj":"Chemical"}],"attributes":[{"id":"A14357","pred":"chebi_id","subj":"T192","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A55812","pred":"chebi_id","subj":"T79903","obj":"http://purl.obolibrary.org/obo/CHEBI_25212"},{"id":"A82644","pred":"chebi_id","subj":"T194","obj":"http://purl.obolibrary.org/obo/CHEBI_18059"},{"id":"A76590","pred":"chebi_id","subj":"T2816","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"}],"text":"N-3 PUFAs and many of the their endogenously generated metabolites act as bioactive lipid molecules with a wide array of properties against numerous disorders including CVD (Lordan, Redfern, Tsoupras, \u0026 Zabetakis, 2020; Lordan, Tsoupras, \u0026 Zabetakis, 2017; Moro, Nagahashi, Ramanathan, Takabe, \u0026 Wakai, 2016)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T460","span":{"begin":0,"end":309},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"N-3 PUFAs and many of the their endogenously generated metabolites act as bioactive lipid molecules with a wide array of properties against numerous disorders including CVD (Lordan, Redfern, Tsoupras, \u0026 Zabetakis, 2020; Lordan, Tsoupras, \u0026 Zabetakis, 2017; Moro, Nagahashi, Ramanathan, Takabe, \u0026 Wakai, 2016)."}

{"project":"2_test","denotations":[{"id":"33031856-32270798-84038922","span":{"begin":214,"end":218},"obj":"32270798"},{"id":"33031856-27458590-84038923","span":{"begin":303,"end":307},"obj":"27458590"}],"text":"N-3 PUFAs and many of the their endogenously generated metabolites act as bioactive lipid molecules with a wide array of properties against numerous disorders including CVD (Lordan, Redfern, Tsoupras, \u0026 Zabetakis, 2020; Lordan, Tsoupras, \u0026 Zabetakis, 2017; Moro, Nagahashi, Ramanathan, Takabe, \u0026 Wakai, 2016)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1781","span":{"begin":84,"end":89},"obj":"Chemical"},{"id":"1782","span":{"begin":140,"end":158},"obj":"Disease"},{"id":"1783","span":{"begin":169,"end":172},"obj":"Disease"}],"attributes":[{"id":"A1781","pred":"tao:has_database_id","subj":"1781","obj":"MESH:D008055"},{"id":"A1782","pred":"tao:has_database_id","subj":"1782","obj":"MESH:D030342"},{"id":"A1783","pred":"tao:has_database_id","subj":"1783","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"N-3 PUFAs and many of the their endogenously generated metabolites act as bioactive lipid molecules with a wide array of properties against numerous disorders including CVD (Lordan, Redfern, Tsoupras, \u0026 Zabetakis, 2020; Lordan, Tsoupras, \u0026 Zabetakis, 2017; Moro, Nagahashi, Ramanathan, Takabe, \u0026 Wakai, 2016)."}